Sophia Abene

Insights on Sofosbuvir levels in pregnant women.

The efficacy of SPIKEVAX from Delta to Omicron protection in pediatric patients.

The impact of polymerase chain reaction (PCR) testing on patient outcomes.

Phase 3 trial evaluates the impact of TCVs in high-risk populations.

Wireless test kit transforms screening efforts towards combating the virus.

How acute malnutrition undermines Malaria in children under 5 years old.

FDA recalls of specific lots of contaminated products.

The Bill & Melinda Gates Medical Research Institute launches the M72/AS01E vaccine in South Africa to combat TB.

CDC on enhancing strategies against drinking water diseases.

High efficacy of Nirsevimab in preventing RSV hospitalizations was revealed.

A vaccine targeting chronic HBV has entered its first human trial; Saskia Popescu, PhD, on the importance of pandemic preparedness and global health security; a successful phase 2 trial for a C diff treatment leads to the next phase; and more stories this week from Contagion.

Insights from Jacob Teitelbaum MD on Long COVID Awareness Day.

Saskia Popescu PhD, MPH, MA, FAPIC on understanding the emergence of the origin for future pandemic preparedness, promoting global health security, and addressing long-term health impacts.

Successful phase 2 trial leads to phase 3 trial towards managing C difficile.

Study proves the role of harnessing CrAgSQ for management over the infection.

Vaccine designed to confront chronic HBV entering its first human clinical trial.

The impact of remdesivir across age groups.

Public health strategy in navigating flu season.

Customizing treatment strategies for enhanced outcomes and longevity.

Climate change's role in the expanding threat of vector-borne diseases.

Defense against omicron in HIV-positive patients post-COVID.

CDC addresses rising vector-borne diseases with an initiative to enhance public health protection.

Insights from CROI on the HepB-CpG vaccine trial.

Unraveling monocyte activation and the implications for cardiovascular risk

Insights from phase 3 study evaluating bulevirtide efficacy in coinfections.

Study shows high efficacy of a 4-week glecaprevir/pibrentasvir regimen for shorter, more manageable treatment duration.

The American Gastroenterological Association guidelines navigating fecal microbiota transplantation in clinical practice.

Study presented at CROI 2024 reveals chronic hepatitis B virus (HBV) infection heightens COVID-19 severity as vaccination reduces mortality and ICU demands in co-infected individuals.

Study presented at CROI 2024 reveals that the introduction of Doxycycline post-exposure prophylaxis (doxy-PEP) guidelines in San Francisco has significantly decreased the incidence of chlamydia and syphilis

Study dives into the complexities of using Oral Vancomycin Prophylaxis to combat Clostridioides difficile in hematopoietic stem cell transplantation recipients with insights from researcher Alexander Vartanov, MD.